The recent large outbreak of Ebola virus disease (EVD) in Western Africa resulted in greatly increased accumulation of human genotypic, phenotypic and clinical data, and improved our understanding of the spectrum of clinical manifestations. As a result, the WHO disease classification of EVD underwent major revision.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Marburg virus disease: the paradox of Nigeria’s preparedness and priority effects in co-epidemics
Bulletin of the National Research Centre Open Access 27 January 2023
-
Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association
Nature Communications Open Access 26 April 2022
-
Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak
One Health Outlook Open Access 04 November 2020
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kuhn, J. H. in Marburg- and Ebolaviruses — From Ecosystems to Molecules (eds Mühlberger, E., Hensley, L. L. & Towner, J. S.) 447–460 (Springer, 2017).
Fukuda, K., Wang, R. & Vallat, B. Naming diseases: first do no harm. Science 348, 643 (2015).
Kupferschmidt, K. Rules of the name. Science 348, 745 (2015).
Acknowledgements
The authors thank Laura Bollinger (US National Institutes of Health (NIH)/US National Institute of Allergy and Infectious Diseases (NIAID) Integrated Research Facility at Fort Detrick, Frederick, MD, USA) for critically reviewing the manuscript. This work was supported in part through Battelle Memorial Institute’s prime contract with the NIAID under Contract No. HHSN272200700016I (J.H.K.). This project was funded in part with federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E (I.C.). G.I. is grateful for support from the Italian Ministry of Health, grant Ricerca Corrente, Research Programme n.1. The UK Public Health Rapid Support Team (D.G.B.) is funded by the UK Department of Health and Social Care.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Disclaimer
The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official views, assertions, opinions or policies, either expressed or implied, of the US Department of Defense, US Department of Health and Human Services (National Institutes of Health; Centers for Disease Control and Prevention), US Uniformed Services University, UK National Health System, the UK National Institute for Health Research, the UK Department of Health and Social Care or of the institutions and companies affiliated with the authors. In no event shall any of these entities have any responsibility or liability for any use, misuse, inability to use, or reliance upon the information contained herein. Some authors are employees of the U.S. Government and as such under the provisions of 17 U.S.C. 105, copyright protection is not available for this work. Mention of trade names, commercial products, or organizations does not imply endorsement by the US Government.
Related links
Supplementary information
Rights and permissions
About this article
Cite this article
Kuhn, J.H., Adachi, T., Adhikari, N.K.J. et al. New filovirus disease classification and nomenclature. Nat Rev Microbiol 17, 261–263 (2019). https://doi.org/10.1038/s41579-019-0187-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41579-019-0187-4
This article is cited by
-
Marburg virus disease: the paradox of Nigeria’s preparedness and priority effects in co-epidemics
Bulletin of the National Research Centre (2023)
-
Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association
Nature Communications (2022)
-
Ebola virus disease
Nature Reviews Disease Primers (2020)
-
Treatment of Ebola-related critical illness
Intensive Care Medicine (2020)
-
Spillover of ebolaviruses into people in eastern Democratic Republic of Congo prior to the 2018 Ebola virus disease outbreak
One Health Outlook (2020)
